Literature DB >> 24664381

Incidence of discontinuation of angiotensin-converting enzyme inhibitors due to cough, in a primary healthcare centre in Singapore.

Lai Peng Ng1, Paul Soo Chye Goh.   

Abstract

INTRODUCTION: The incidence of cough induced by angiotensin-converting enzyme (ACE) inhibitors has been reported to be 5%-20%, with less than half of affected patients requiring discontinuation due to persistent cough. However, the incidence in the local Asian population has not been studied. This study aimed to objectively evaluate the incidence of discontinuation of ACE inhibitors due to cough, in a primary healthcare centre in Singapore.
METHODS: We retrospectively reviewed the medical records, both electronic and written, of patients who attended Tampines Polyclinic to identify those who were newly prescribed ACE inhibitors. The written medical records were analysed to identify patients who discontinued the use of ACE inhibitors and to find out the reasons for discontinuation.
RESULTS: A total of 424 patients were identified during the study period. Out of the 424 patients, 129 (30.4%) discontinued the use of ACE inhibitors due to cough. Overall, 90 (21.2%) patients who were initially started on ACE inhibitors were eventually switched to angiotensin receptor blockers (ARBs).
CONCLUSION: In our cohort, the incidence of discontinuation of ACE inhibitors due to cough is higher than most other studies. The relationship between ethnicity and tolerance of medications should not be underestimated. As there is a high incidence of discontinuation of ACE inhibitors due to cough in the local population, ARBs may be a reasonable substitute as a first-line medication, if clinically indicated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664381      PMCID: PMC4293986          DOI: 10.11622/smedj.2014034

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  12 in total

Review 1.  Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

Authors:  Peter V Dicpinigaitis
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

2.  Ethnic and gender differences in cough reflex sensitivity.

Authors:  P V Dicpinigaitis; V R Allusson; A Baldanti; J R Nalamati
Journal:  Respiration       Date:  2001       Impact factor: 3.580

Review 3.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

4.  Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects.

Authors:  W J Elliott
Journal:  Clin Pharmacol Ther       Date:  1996-11       Impact factor: 6.875

5.  Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure.

Authors:  D Ravid; M Lishner; R Lang; M Ravid
Journal:  J Clin Pharmacol       Date:  1994-11       Impact factor: 3.126

6.  Postmarketing surveillance of captopril for hypertension.

Authors:  D Chalmers; A Whitehead; D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

7.  ACE inhibitors and cough.

Authors:  S Yeşil; M Yeşil; S Bayata; N Postaci
Journal:  Angiology       Date:  1994-09       Impact factor: 3.619

8.  Persistent dry cough with enalapril: incidence depends on method used.

Authors:  W W Yeo; L E Ramsay
Journal:  J Hum Hypertens       Date:  1990-10       Impact factor: 3.012

9.  High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.

Authors:  K S Woo; M G Nicholls
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

10.  Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice.

Authors:  W D Cooper; D Sheldon; D Brown; G R Kimber; V L Isitt; W J Currie
Journal:  J R Coll Gen Pract       Date:  1987-08
View more
  14 in total

Review 1.  Tolerability of Antihypertensive Medications in Older Adults.

Authors:  Thiruvinvamalai S Dharmarajan; Lekshmi Dharmarajan
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

2.  Let it go.

Authors:  Choon How How
Journal:  Singapore Med J       Date:  2014-03       Impact factor: 1.858

3.  Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.

Authors:  Seyed Hamidreza Mahmoudpour; Ekaterina Vitalievna Baranova; Patrick C Souverein; Folkert W Asselbergs; Anthonius de Boer; Anke Hilse Maitland-van der Zee
Journal:  Br J Clin Pharmacol       Date:  2016-10-04       Impact factor: 4.335

4.  Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer.

Authors:  Sarah R Hosford; Lloye M Dillon; Stephanie J Bouley; Rachele Rosati; Wei Yang; Vivian S Chen; Eugene Demidenko; Rocco P Morra; Todd W Miller
Journal:  Clin Cancer Res       Date:  2016-11-30       Impact factor: 12.531

Review 5.  Approaching chronic cough.

Authors:  Vijo Poulose; Pei Yee Tiew; Choon How How
Journal:  Singapore Med J       Date:  2016-02       Impact factor: 1.858

6.  Incidence of angiotensin-converting enzyme inhibitor-induced cough in a Malaysian public primary care clinic: A retrospective cohort study.

Authors:  Hou Chan Loo; Fairuz Osman; Siew Lee Ho; Sing Yee An; Yim Mei Au Yong; Ee Ming Khoo
Journal:  Malays Fam Physician       Date:  2022-03-22

7.  The Incidence of Antihypertensive Drug-induced Side Effects in Patients with Diabetes Mellitus Type 2 and Hypertension.

Authors:  Svjetlana Loga-Zec; Mensura Asceric; Natasa Loga-Andrijic; Berina Kapetanovic; Enver Zerem
Journal:  Med Arch       Date:  2014-12-16

8.  Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Sungmin Lim; Eun Ho Choo; Ik Jun Choi; Sang Hyun Ihm; Hee Yeol Kim; Youngkeun Ahn; Kiyuk Chang; Myung Ho Jeong; Ki Bae Seung
Journal:  J Korean Med Sci       Date:  2019-11-25       Impact factor: 2.153

9.  A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.

Authors:  Lung-Sheng Wu; Shang-Hung Chang; Gwo-Jyh Chang; Jia-Rou Liu; Yi-Hsin Chan; Hsin-Fu Lee; Ming-Shien Wen; Wei-Jan Chen; Yung-Hsin Yeh; Chi-Tai Kuo; Lai-Chu See
Journal:  Cardiovasc Diabetol       Date:  2016-04-02       Impact factor: 9.951

10.  Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.

Authors:  Fu-Chih Hsiao; Ying-Chang Tung; Shing-Hsien Chou; Lung-Sheng Wu; Chia-Pin Lin; Chun-Li Wang; Yu-Sheng Lin; Chee-Jen Chang; Pao-Hsien Chu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.